SignatureFD’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

SignatureFD’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-569	Closed	-$504	–	3433
2022 Q4	$504	Buy	+569	New	+$755	﹤0.01%	3109
2022 Q2	–	Sell	-1,724	Closed	-$4K	–	3430
2022 Q1	$4K	Buy	+1,724	New	+$5.38K	﹤0.01%	2638
2021 Q4	–	Sell	-191	Closed	-$1K	–	3344
2021 Q3	$1K	Buy	+191	New	+$1.62K	﹤0.01%	2983
2021 Q2	–	Sell	-510	Closed	-$4K	–	3113
2021 Q1	$4K	Buy	+510	New	+$5.38K	﹤0.01%	2292
2020 Q3	–	Sell	-459	Closed	-$3K	–	2812
2020 Q2	$3K	Buy	+459	New	+$1.76K	﹤0.01%	2048

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return